About BIOCRYST PHARMACEUTICALS INC
BioCryst is a global biotechnology company with over three decades of experience in drug discovery, development, and commercialization, focusing on rare diseases such as hereditary angioedema (HAE). The company is committed to delivering novel, first-in-class or best-in-class oral small-molecule and injectable protein therapeutics.
Drug discovery and developmentStructure-guided drug designCommercialization of therapeutics for rare diseasesDevelopment of oral small-molecule and injectable protein therapeutics
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| EMERGENCY ORLADEYO | Department of Veterans Affairs | $30K | |
| Federal contract award | Department of Health and Human Services | $34.7M | |
| PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN)) | Department of Health and Human Services | $13.9M | |
| BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP | Department of Veterans Affairs | $379K | |
| Federal contract award | Department of Veterans Affairs | $57K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BIOCRYST PHARMACEUTICALS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.